CPAI Counterpoint Quantitative Equity ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| PBF | 3.76% |
| SEDG | 3.25% |
| DK | 3.15% |
| ECO | 3.02% |
| YOU | 2.86% |
| TSEM | 2.73% |
| Q | 2.68% |
| AAP | 2.68% |
| BKD | 2.55% |
| ZIM | 2.49% |
ETF Analysis
Fund Overview
Counterpoint Quantitative Equity ETF (CPAI) currently reports 50 stock positions (subject to change), placing it in the neither concentrated nor index-like range by holdings breadth. The top line-up is PBF (3.76%), SEDG (3.25%), DK (3.15%), with PBF as the largest single weight at 3.76%. Together, the top three holdings account for 10.16%, which indicates that idiosyncratic risk at the top of the book is relatively contained within the overall portfolio. The resulting profile combines thematic conviction with varying degrees of diversification, which can support upside participation while still spreading idiosyncratic risk beyond the top weights.
Profitability & Capital Efficiency
From a returns-on-capital standpoint, ROIC is -1.12%, WACC is 8.74%, and the economic spread is -9.86%. On balance, ROIC falls short of WACC, meaning the portfolio's holdings are not yet generating returns sufficient to cover their cost of capital. Supporting metrics show ROE at -18.56% and ROA at 2.27%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio that likely needs operating improvement before returns quality can be considered durable.
Valuation
The current pricing of the underlying holdings reads trailing P/E of 16.15, forward P/E of 13.22, PEG of 1.31. The small spread between trailing and forward P/E suggests neither meaningful acceleration nor deterioration is currently priced into the earnings outlook. The PEG ratio is low enough to suggest the valuation is supported by earnings growth expectations rather than multiple expansion alone. The aggregate current ratio of 3.81 points to strong liquidity across holdings. In aggregate, the valuation reads as fair to moderately stretched — leaving the investment case dependent on earnings execution rather than multiple expansion.
Margins & Cash Generation
On profitability at each income statement layer, gross margin sits at 40.97%, operating margin at -4.68%, and free cash flow margin at 15.43%. The portfolio's gross margins are solid, reflecting a reasonable balance between revenue realization and direct cost absorption. Operating margins are negligible or negative, which is typical of portfolios with heavy exposure to businesses still building toward profitability. Free cash flow margins are strong, reflecting capital-efficient businesses that largely self-fund their growth. Taken together, the margin stack suggests quality that is uneven — some layers are more resilient than others, and that asymmetry matters under stress.
Growth & Forward Outlook
Looking at what the businesses are actually delivering versus what analysts are pricing in, TTM revenue growth of 23.34% indicating that revenue growth remains a meaningful tailwind for the portfolio. At the same time, the estimated 12-month price change of 25.04%, where implied upside appears constructive but not aggressive. Revenue growth captures operating momentum, while price targets reflect external expectations that can move with rates, risk appetite, and sector sentiment. Whether current momentum translates into delivered returns will depend on the durability of both top-line trends and the assumptions embedded in analyst targets. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
BuyPutting the pieces together, this is a profile with genuine merit: the numbers support confidence in the forward case without requiring heroic assumptions.
These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.